# Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML

> **NCT07338357** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Guangxi Medical University** · enrollment: 10 (estimated)

## Conditions studied

- AML (Acute Myeloid Leukemia)
- CAR-T

## Interventions

- **BIOLOGICAL:** CAR-T

## Key facts

- **NCT ID:** NCT07338357
- **Lead sponsor:** First Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-05
- **Primary completion:** 2028-10-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07338357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07338357, "Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07338357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*